Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Platinum × Clear all

NCT06351332 2026-01-12

ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC

Phase 1/2 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms